share_log

Pfizer | DEFA14A: Others

SEC announcement ·  Apr 11 23:00
Summary by Futu AI
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement schedule 14A, in accordance with Section 14(a) of the Securities Exchange Act of 1934. The materials were submitted by Pfizer as the registrant, indicating that no third party was involved in the filing. The company has confirmed that no filing fee was required for this submission. The purpose of the filing and the contents of the additional materials have not been specified in the announcement.
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement schedule 14A, in accordance with Section 14(a) of the Securities Exchange Act of 1934. The materials were submitted by Pfizer as the registrant, indicating that no third party was involved in the filing. The company has confirmed that no filing fee was required for this submission. The purpose of the filing and the contents of the additional materials have not been specified in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.